We came across a bullish thesis on AbCellera Biologics Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.'s share was trading at $5.98 as of October 2nd. ABCL’s trailing P/E was 19.92 according to Yahoo Finance.
[caption id="attachment_522182" align="aligncenter" width="750"]Abcellera is emerging as a highly promising biotechnology platform with the potential for exponential earnings growth over the next year,...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.